BIM
AZN icon

Breakwater Investment Management’s AstraZeneca AZN Stock Holding History

Breakwater Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-357
Closed -$48.3K – 318
2024
Q1 		$48.3K Buy
+357
New +$47.3K 0.02% 143

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Breakwater Investment Management's AZN Position: Q2 2024 in Review

Breakwater Investment Management sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 357 shares — an estimated $48.3K sold.

Breakwater Investment Management first reported a position in AZN in Q1 2024 and held it in 1 quarter. The position peaked at $48.3K in Q1 2024. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Breakwater Investment Management reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Breakwater Investment Management sold 357 AstraZeneca shares in Q2 2024, an estimated $48.3K.
  • Breakwater Investment Management first reported a position in AstraZeneca in Q1 2024 and held it in 1 quarter.
  • Breakwater Investment Management's AstraZeneca position peaked at $48.3K in Q1 2024.
  • 1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Breakwater Investment Management's 13F filing for Q2 2024, filed 8 Aug 2024.